Rocket Lab projects $250M-$265M Q3 2026 revenue as it targets mid-2027 Iridium close
Rocket Lab is targeting a mid-2027 Iridium close, projecting third-quarter 2026 revenue between $250 million and $265 million.
The current price is near the 20-day high resistance level, and there is a possibility of profit-taking sales due to the recent surge over the past 7 days. Therefore, I will consider entering while keeping in mind both the potential for a breakout above the resistance level and risk management based on the support level.
Considering the possibility of profit-taking selling, I will take profits if the price reaches the high resistance level of $83.25 on the 20th, and I will cut losses if the low support level of $58.20 on the 20th is breached.
The technical indicators at the entry point are RSI(14) at 68.6, moving averages are misaligned, trading volume is 1.30 times the 20-day average, and the recent 7-day volatility is +41.3%.
Similar daily fluctuation patterns have been observed in the past, such as +2.5% on 2026-08-13 and +2.6% on 2026-08-11.
At the time of the forecast, a cautious approach was taken considering the possibility of profit-taking near the 20-day high resistance level ($83.25). However, the actual result was a FAILED rating with a significant drop of -12.9% towards the stop-loss price ($58.20). The recent surge of +41.3% over the past 7 days, the entry into the overbought territory with an RSI of 68.6, and the dilution risk from the CRITICAL rating of the 424B5 new share/securities offering announcement appear to have exerted strong downward pressure on the stock price.
This trading experience has reaffirmed the necessity of conservative risk management when fatigue from short-term surges and high RSI levels are detected. In particular, it is important to keep in mind that when shareholder dilution factors, such as offering announcements, accompany the situation, it becomes difficult to maintain an upward trend even in the presence of positive news. Therefore, we will apply stricter stop-loss criteria and disclosure monitoring for future entries.